ROCKWELL MEDICAL, INC. Increase (Decrease) in Prepaid Expense and Other Assets
ROCKWELL MEDICAL, INC. (RMTI) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$732.00K.
- ROCKWELL MEDICAL, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$426.00K.
- ROCKWELL MEDICAL, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $78.00K, a 53.29% decline year-over-year.
- ROCKWELL MEDICAL, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $573.00K, a 14225.00% increase year-over-year.
- ROCKWELL MEDICAL, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$392.00K.
- ROCKWELL MEDICAL, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$374.00K.
- ROCKWELL MEDICAL, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.41M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$732.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.16M 10-Q · filed 2026-08-13 | -$1.08M derived: sum of 3 quarters · filed 2026-08-13 | -$507.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$426.00K 10-Q · filed 2026-05-07 | -$348.00K derived: sum of 2 quarters · filed 2026-05-07 | $225.00K derived: sum of 3 quarters · filed 2026-05-07 | -$440.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $78.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $651.00K derived: sum of 2 quarters · filed 2026-03-26 | -$14.00K derived: sum of 3 quarters · filed 2026-08-13 | -$392.00K 10-K · filed 2026-03-26 | ||
| 2025-09-30 | $573.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$92.00K derived: sum of 2 quarters · filed 2026-08-13 | -$470.00K 10-Q · filed 2025-11-12 | -$303.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | -$665.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$1.04M 10-Q · filed 2026-08-13 | -$876.00K derived: sum of 3 quarters · filed 2026-08-13 | -$872.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$378.00K 10-Q · filed 2026-05-07 | -$211.00K derived: sum of 2 quarters · filed 2026-05-07 | -$207.00K derived: sum of 3 quarters · filed 2026-05-07 | -$599.00K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $171.00K derived: sum of 2 quarters · filed 2026-03-26 | -$221.00K derived: sum of 3 quarters · filed 2026-03-26 | -$374.00K 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$388.00K derived: sum of 2 quarters · filed 2025-11-12 | -$541.00K 10-Q · filed 2025-11-12 | -$1.08M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | -$392.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$545.00K 10-Q · filed 2025-08-14 | -$1.08M derived: sum of 3 quarters · filed 2025-08-14 | -$957.00K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | -$153.00K 10-Q · filed 2025-05-12 | -$688.00K derived: sum of 2 quarters · filed 2025-05-12 | -$565.00K derived: sum of 3 quarters · filed 2025-05-12 | -$1.06M derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | -$535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$412.00K derived: sum of 2 quarters · filed 2025-03-20 | -$905.00K derived: sum of 3 quarters · filed 2025-03-20 | -$1.41M 10-K · filed 2025-03-20 | ||
| 2023-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$370.00K derived: sum of 2 quarters · filed 2024-11-12 | -$875.00K 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | -$493.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$998.00K 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | -$505.00K 10-Q · filed 2024-05-14 | |||||
| 2022-09-30 | -$783.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.43M derived: sum of 2 quarters · filed 2023-11-14 | -$2.06M 10-Q · filed 2023-11-14 | |||
| 2022-06-30 | -$645.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.27M 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | -$630.00K 10-Q · filed 2023-05-15 | |||||
| 2021-09-30 | -$467.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$1.44M derived: sum of 2 quarters · filed 2022-11-14 | -$1.76M 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | -$976.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$1.29M 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | -$317.00K 10-Q · filed 2022-05-16 | |||||
| 2020-09-30 | -$769.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $932.00K derived: sum of 2 quarters · filed 2021-11-15 | -$161.00K 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $608.00K 10-Q · filed 2021-08-16 | $607.57K 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | -$1.09M 10-Q · filed 2021-05-17 | -$1.09M 10-Q · filed 2020-05-11 | ||||
| 2019-09-30 | -$805.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$727.02K derived: sum of 2 quarters · filed 2020-11-09 | -$931.00K 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $78.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$125.75K 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | -$203.98K 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |